Philippa R Kennedy

11PUBLICATIONS

92CO-AUTHORS

Micro- and nanosystemsPredictive and prognostic markersQuery processing and optimisationMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 13, 2026

Reprogramming endogenous NK circuits by highly efficient nonviral genome editing.

|Apr 21, 2026

B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient Groups.

|Apr 03, 2026

NetTracer3D Enables User-Friendly Analysis of Diverse Microscopic and Medical 3D Datasets.

Liam Mclaughlin, Mia Curic, Siddhartha Sharma

|Oct 26, 2025

HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.

Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai

|Jul 24, 2025

Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.

Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy

|Nov 15, 2024

A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.

Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier

Pageof 2

Frequent Collaborators

Martin Felices

Nicholas A Zorko

Jeffrey S Miller

Quinlan M Kile

Emmanuel S Antonarakis

Shee Kwan Phung

Melissa Khaw

Xianghua Luo

Peter Hinderlie

Laura E Bendzick

Frequent Collaborators

Martin Felices

Nicholas A Zorko

Jeffrey S Miller

Quinlan M Kile